SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286,397 | +22.1% | 6,091 | +9.0% | 0.00% | 0.0% |
| Q1 2023 | $234,513 | +1703.9% | 5,589 | +1290.3% | 0.00% | – |
| Q2 2022 | $13,000 | -35.0% | 402 | -32.8% | 0.00% | – |
| Q1 2022 | $20,000 | +100.0% | 598 | +160.0% | 0.00% | – |
| Q4 2021 | $10,000 | -47.4% | 230 | -47.6% | 0.00% | – |
| Q3 2021 | $19,000 | -36.7% | 439 | -16.9% | 0.00% | – |
| Q2 2021 | $30,000 | -23.1% | 528 | +2.3% | 0.00% | – |
| Q1 2021 | $39,000 | -50.0% | 516 | -42.9% | 0.00% | -100.0% |
| Q4 2020 | $78,000 | +1014.3% | 903 | +692.1% | 0.00% | – |
| Q3 2020 | $7,000 | +40.0% | 114 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +400.0% | 114 | +2750.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 4 | -69.2% | 0.00% | – |
| Q1 2018 | $2,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |